Trial Profile
A phase II study of CEP-41750 for the treatment of acute myocardial infarction
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2014
Price :
$35
*
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2014 New trial record